Considering photodynamic therapy as a therapeutic modality in selected cases of dome-shaped macula complicated by foveal serous retinal detachment

Ophthalmic Surg Lasers Imaging Retina. 2015 Feb;46(2):217-23. doi: 10.3928/23258160-20150213-15.

Abstract

Background and objective: To study the role of photodynamic therapy (PDT) as a therapeutic modality in myopic patients with dome-shaped macula (DSM) associated with foveal serous retinal detachment (SRD).

Patients and methods: Retrospective interventional case series. The medical records of 10 consecutive myopic patients (10 eyes) with DSM associated with subfoveal SRD and treated with PDT were reviewed. Visual gain and loss were considered as increasing or decreasing of two or more lines of best corrected visual acuity (BCVA), respectively, and eyes with fluid resolution were deemed responsive to PDT.

Results: All eyes underwent several PDT treatments, with a median of three and a median follow-up time of 15.5 months. At final follow-up, six eyes (60%) showed complete resolution of the foveal SRD. The baseline hypocyanescent macular area observed during late indocyanine green angiography (ICGA) frames was significantly lower in the group of patients who responded to PDT and had an increase of at least two Snellen lines in BCVA (P = .01).

Conclusion: Data suggest that myopic eyes associated with DSM and foveal SRD may be responsive to PDT, showing total resolution of fluid accumulation and positive BCVA changes if baseline ICGA findings show evidence of a limited hypocyanescent macular area.

MeSH terms

  • Adult
  • Aged
  • Coloring Agents
  • Dilatation, Pathologic
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Fovea Centralis / drug effects*
  • Fovea Centralis / pathology
  • Humans
  • Indocyanine Green
  • Macula Lutea / drug effects*
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Myopia / complications
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Porphyrins / therapeutic use
  • Retinal Detachment / diagnosis
  • Retinal Detachment / drug therapy*
  • Retinal Detachment / etiology
  • Retinal Diseases / complications
  • Retinal Diseases / diagnosis
  • Retinal Diseases / drug therapy*
  • Retrospective Studies
  • Subretinal Fluid*
  • Tomography, Optical Coherence
  • Verteporfin
  • Visual Acuity / physiology

Substances

  • Coloring Agents
  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin
  • Indocyanine Green